Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

429
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
429
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

56
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
56
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
Schizophrenia01:17

Schizophrenia

57
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
57
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

35
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FreeSurfer-Based MRI Volumetry Reveals Thalamic and Hippocampal Atrophy as Significant Correlates of Disability in Multiple Sclerosis.

Medicina (Kaunas, Lithuania)·2026
Same author

Nationwide epidemiological study of neuromyelitis optica spectrum disorder in Serbia.

Multiple sclerosis and related disorders·2025
Same author

Determination of systemic inflammatory biomarkers in multiple sclerosis.

Journal of medical biochemistry·2024
Same author

VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS.

Acta clinica Croatica·2022
Same author

The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries.

Multiple sclerosis and related disorders·2017
Same author

Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report.

Vojnosanitetski pregled·2015

Related Experiment Video

Updated: May 27, 2025

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.6K

EARLY ONSET OF MULTIPLE SCLEROSIS - CLINICAL FEATURES.

Vesna Suknjaja1,2, Lorand Sakalaš1,2, Miroslav Ilin3

  • 1University Clinical Center of Vojvodina, Department of Neuroinflammation and Demyelinization, Novi Sad, Serbia.

Acta Clinica Croatica
|February 17, 2025
PubMed
Summary

Pediatric multiple sclerosis (MS) onset presents unique challenges. This study found early-onset MS symptoms and disease courses in children are similar to those in adults.

Keywords:
Key words: Multiple sclerosis, pediatricClinical presentation of diseaseMultiple sclerosis, adulthood

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.3K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.6K

Related Experiment Videos

Last Updated: May 27, 2025

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.6K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.3K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.6K

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Neuroimmunology

Background:

  • Childhood-onset multiple sclerosis (MS) presents diagnostic difficulties.
  • Understanding early-onset MS is crucial for timely diagnosis and management.
  • Comparing pediatric MS to adult MS provides insights into disease heterogeneity.

Purpose of the Study:

  • To analyze parameters of early-onset MS in children compared to adult MS patients.
  • To investigate differences and similarities in initial symptoms and disease course.
  • To enhance diagnostic and treatment strategies for pediatric MS.

Main Methods:

  • Retrospective analysis of patients with central nervous system demyelinating disease.
  • Categorization into pediatric (onset <18 years, n=52) and adult (20-55 years) groups.
  • Comparison of initial symptoms, polysymptomatic onset, and time to second relapse.

Main Results:

  • Children rarely presented with polysymptomatic onset (p=0.020).
  • Initial symptoms in children: optic neuritis (35.3%) and ataxia (35.3%).
  • Initial symptoms in adults: sensory disturbances (41.6%) and pyramidal symptoms (37.6%).
  • Second relapse occurred in 78.4% of pediatric patients (median 12 months) and 78.2% of adults (median 9 months).

Conclusions:

  • Initial clinical manifestations of MS in children are comparable to those in adults.
  • Disease course parameters, including relapse rates, show similarities between pediatric and adult MS.
  • Findings suggest a unified approach to MS management, with consideration for age-specific nuances.